{"id":26361,"date":"2024-07-26T13:55:52","date_gmt":"2024-07-26T20:55:52","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=26361"},"modified":"2025-07-16T16:38:38","modified_gmt":"2025-07-16T23:38:38","slug":"cidp-vs-als-what-is-the-difference","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/","title":{"rendered":"CIDP vs. ELA: \u00bfCu\u00e1l es la diferencia?"},"content":{"rendered":"<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/what-is-cidp\/\">Polineuropat\u00eda desmielinizante inflamatoria cr\u00f3nica<\/a> (CIDP) y <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/amyotrophic-lateral-sclerosis\/symptoms-causes\/syc-20354022\">esclerosis lateral amiotr\u00f3fica<\/a>&nbsp;(ELA) son trastornos neurol\u00f3gicos poco frecuentes y debilitantes. Si bien ambas afecciones afectan las funciones nerviosas y musculares, difieren significativamente en el tipo de nervios afectados, las causas, los signos y s\u00edntomas, la progresi\u00f3n y la prevalencia.<strong>,<\/strong> diagn\u00f3stico y tratamiento.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-7b1f1bdb875455a6e74f75b196ee4e7b\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Este art\u00edculo analiza las diferencias clave entre estos trastornos para ayudar a los pacientes a recibir el tratamiento adecuado.&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/#What_Is_Chronic_Inflammatory_Demyelinating_Polyneuropathy_CIDP\" >\u00bfQu\u00e9 es la polineuropat\u00eda desmielinizante inflamatoria cr\u00f3nica (PDIC)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/#What_Is_Amyotrophic_Lateral_Sclerosis_ALS\" >\u00bfQu\u00e9 es la esclerosis lateral amiotr\u00f3fica (ELA)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/#CIDP_vs_ALS_Causes\" >CIDP vs. ELA: Causas&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/#CIDP_vs_ALS_Key_Signs_and_Symptoms\" >CIDP vs. ELA: Signos y s\u00edntomas clave<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/#CIDP_vs_ALS_Disease_Progression\" >PDIC versus ELA: progresi\u00f3n de la enfermedad<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/#CIDP_vs_ALS_Prevalence\" >CIDP vs. ELA: Prevalencia<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/#CIDP_vs_ALS_Diagnosis_and_Treatment_Strategies\" >CIDP vs. ELA: Diagn\u00f3stico y estrategias de tratamiento<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/#Summary\" >Resumen<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-chronic-inflammatory-demyelinating-polyneuropathy-cidp\"><span class=\"ez-toc-section\" id=\"What_Is_Chronic_Inflammatory_Demyelinating_Polyneuropathy_CIDP\"><\/span><strong>\u00bfQu\u00e9 es la polineuropat\u00eda desmielinizante inflamatoria cr\u00f3nica (PDIC)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La CIDP es un trastorno autoinmune poco com\u00fan y cr\u00f3nico que afecta principalmente a los nervios del sistema nervioso perif\u00e9rico. En esta afecci\u00f3n, el sistema inmunitario ataca y destruye por error la vaina de mielina, la capa protectora que recubre las fibras nerviosas.&nbsp;<\/p>\n\n\n\n<p>La inflamaci\u00f3n excesiva causada por un ataque autoinmune da\u00f1a los nervios perif\u00e9ricos, lo que produce debilidad muscular progresiva, p\u00e9rdida de fuerza y problemas sensoriales.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-is-amyotrophic-lateral-sclerosis-nbsp-als\"><span class=\"ez-toc-section\" id=\"What_Is_Amyotrophic_Lateral_Sclerosis_ALS\"><\/span><strong>\u00bfQu\u00e9 es la esclerosis lateral amiotr\u00f3fica (ELA)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La esclerosis lateral amiotr\u00f3fica (ELA) es un trastorno neurodegenerativo progresivo que afecta a las c\u00e9lulas nerviosas motoras del sistema nervioso central (nervios motores del cerebro y la m\u00e9dula espinal). Los nervios motores controlan principalmente la respiraci\u00f3n y los movimientos musculares voluntarios. Cuando las se\u00f1ales nerviosas no se transmiten correctamente al m\u00fasculo debido a la degeneraci\u00f3n de las neuronas motoras, este se debilita y comienza a contraerse.&nbsp;<\/p>\n\n\n\n<p>La ELA tambi\u00e9n se conoce a veces como enfermedad de Lou Gehrig y enfermedad de la neurona motora (EMN).&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cidp-vs-als-causes-nbsp\"><span class=\"ez-toc-section\" id=\"CIDP_vs_ALS_Causes\"><\/span><strong>CIDP vs. ELA: Causas&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La causa exacta de ambas afecciones neurol\u00f3gicas a\u00fan no se conoce con certeza. Sin embargo, se ha descubierto que una anomal\u00eda del sistema inmunitario causa la PDIC, raz\u00f3n por la cual se la conoce como una enfermedad autoinmune.<\/p>\n\n\n\n<p>La ELA se considera una enfermedad hereditaria, ya que diversos estudios de investigaci\u00f3n han destacado un v\u00ednculo gen\u00e9tico. Por ejemplo, mutaciones en genes espec\u00edficos como C9orf72, ARDBP y FUS pueden provocar ELA, ya que estos genes regulan el funcionamiento normal de las neuronas motoras. Esta forma de ELA se conoce como ELA familiar.&nbsp;<\/p>\n\n\n\n<p>Seg\u00fan las estimaciones, una <a href=\"https:\/\/medlineplus.gov\/genetics\/condition\/amyotrophic-lateral-sclerosis\/#causes\">Se ha encontrado una mutaci\u00f3n gen\u00e9tica en 60% de personas con ELA familiar.<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cidp-vs-als-key-signs-and-symptoms\"><span class=\"ez-toc-section\" id=\"CIDP_vs_ALS_Key_Signs_and_Symptoms\"><\/span><strong>CIDP vs. ELA: Signos y s\u00edntomas clave<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La presentaci\u00f3n cl\u00e1sica de la PDIC es una debilidad muscular sim\u00e9trica, especialmente en las piernas, que posteriormente se extiende a los brazos. Los pacientes con PDIC tambi\u00e9n pueden experimentar los siguientes s\u00edntomas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>P\u00e9rdida de reflejos<\/li>\n\n\n\n<li>Sensaci\u00f3n de hormigueo y entumecimiento en brazos y piernas.<\/li>\n\n\n\n<li>P\u00e9rdida del equilibrio y dificultad para caminar&nbsp;<\/li>\n<\/ul>\n\n\n\n<p>Por lo general, los s\u00edntomas de la CIDP se desarrollan gradualmente a lo largo de varios meses.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/arms-tingling-1.jpg\" alt=\"Close-up of hands with a tingling sensation, representing symptoms of neurological disorders.\" class=\"wp-image-26366\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/arms-tingling-1.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/arms-tingling-1-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/arms-tingling-1-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/arms-tingling-1-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/arms-tingling-1-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/arms-tingling-1-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/arms-tingling-1-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Por otro lado, la ELA afecta principalmente la funci\u00f3n motora, lo que provoca rigidez, espasmos o calambres y debilitamiento muscular. Por lo general, estos s\u00edntomas se presentan primero en una pierna (presentaci\u00f3n asim\u00e9trica) antes de extenderse a otras regiones del cuerpo. Adem\u00e1s, a medida que la afecci\u00f3n empeora, los pacientes con ELA tambi\u00e9n experimentan:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>P\u00e9rdida de peso<\/li>\n\n\n\n<li>atrofia muscular<\/li>\n\n\n\n<li>Dificultad para hablar (disartria)<\/li>\n\n\n\n<li>Dificultad para masticar o tragar (disfagia)<\/li>\n<\/ul>\n\n\n\n<p>Sin embargo, en la ELA, las funciones sensoriales en su mayor parte no se ven afectadas y los pacientes no experimentan hormigueo ni entumecimiento.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-d7a33ba5cbc7eeabe1df61ba620ef98d\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista \t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cidp-vs-als-disease-progression\"><span class=\"ez-toc-section\" id=\"CIDP_vs_ALS_Disease_Progression\"><\/span><strong>PDIC versus ELA: progresi\u00f3n de la enfermedad<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La CIDP es una enfermedad rara y de larga duraci\u00f3n que progresa gradualmente y alcanza su estado grave despu\u00e9s de 8 semanas.&nbsp;<\/p>\n\n\n\n<p>Por otro lado, cuando la ELA comienza, progresa r\u00e1pidamente y empeora con el tiempo.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cidp-vs-als-prevalence\"><span class=\"ez-toc-section\" id=\"CIDP_vs_ALS_Prevalence\"><\/span><strong>CIDP vs. ELA: Prevalencia<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Seg\u00fan NORD, <a href=\"https:\/\/rarediseases.org\/rare-diseases\/chronic-inflammatory-demyelinating-polyneuropathy\/\">alrededor de 5 a 7 casos de CIDP por cada 100.000 personas<\/a> Se reportan anualmente. La PDIC puede presentarse en cualquier grupo de edad, pero es m\u00e1s frecuente en personas mayores (de 50 a 60 a\u00f1os). Los hombres tienen mayor riesgo de PDIC que las mujeres. Adem\u00e1s, existe la posibilidad de que la PDIC reaparezca despu\u00e9s del tratamiento.&nbsp;<\/p>\n\n\n\n<p>Por el contrario, la ELA afecta a entre 2 y 5 personas de cada 100.000 individuos en todo el mundo. <a href=\"https:\/\/www.cdc.gov\/als\/abouttheregistrymain\/index.html\">y casi 32.000 personas viven con ELA en los Estados Unidos<\/a>El trastorno de ELA puede atacar a cualquier edad, pero los s\u00edntomas se desarrollan principalmente despu\u00e9s de los 50 a\u00f1os o entre los 50 y los 75 a\u00f1os.&nbsp;<\/p>\n\n\n\n<p>Al igual que la CIDP, la ELA tambi\u00e9n es m\u00e1s com\u00fan en hombres que en mujeres.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cidp-vs-als-diagnosis-and-treatment-strategies\"><span class=\"ez-toc-section\" id=\"CIDP_vs_ALS_Diagnosis_and_Treatment_Strategies\"><\/span><strong>CIDP vs. ELA: Diagn\u00f3stico y estrategias de tratamiento<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El diagn\u00f3stico de PDIC y ELA es dif\u00edcil debido a la variaci\u00f3n de los s\u00edntomas. Sin embargo, los m\u00e9dicos realizan diversas pruebas, como electromiograf\u00eda, prueba de conducci\u00f3n nerviosa, biopsia nerviosa\/muscular, resonancia magn\u00e9tica, punci\u00f3n lumbar y an\u00e1lisis de sangre, para confirmar el diagn\u00f3stico de ELA y PDIC.&nbsp;<\/p>\n\n\n\n<p>Aunque los m\u00e9dicos siguen los mismos procedimientos de diagn\u00f3stico para la CIDP y la ELA, sus estrategias de tratamiento difieren.&nbsp;<\/p>\n\n\n\n<p>En el caso del trastorno CIDP, las tres terapias est\u00e1ndar son las siguientes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Corticosteroides<\/li>\n\n\n\n<li>Intercambio de plasma<\/li>\n\n\n\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig\/\">Terapia con IgIV<\/a><\/li>\n<\/ul>\n\n\n\n<p>En el caso de la ELA, ning\u00fan tratamiento puede revertir el da\u00f1o del nervio motor. Sin embargo, algunos medicamentos (como el riluzol, la edaravona y el tofersen) aprobados por la FDA, as\u00ed como la rehabilitaci\u00f3n (como la fisioterapia, la terapia ocupacional y la logopedia), pueden ayudar a retrasar la progresi\u00f3n de la enfermedad, mejorar la calidad de vida y prolongar la esperanza de vida de los pacientes.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-summary\"><span class=\"ez-toc-section\" id=\"Summary\"><\/span><strong>Resumen<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La PDIC es un trastorno autoinmune que afecta al sistema nervioso perif\u00e9rico, mientras que la ELA es una enfermedad neurodegenerativa que afecta a los nervios motores del sistema nervioso central. Si bien ambas afecciones tienen diferentes causas, s\u00edntomas, ritmo de progresi\u00f3n y procedimientos de tratamiento, comparten los mismos procedimientos de diagn\u00f3stico. Comprender estas diferencias clave puede ayudar a controlar la afecci\u00f3n y mejorar la calidad de vida de los pacientes.<\/p>","protected":false},"excerpt":{"rendered":"<p>La polineuropat\u00eda desmielinizante inflamatoria cr\u00f3nica (PDIC) y la esclerosis lateral amiotr\u00f3fica (ELA) son trastornos neurol\u00f3gicos poco frecuentes y debilitantes. Si bien ambas afecciones afectan la funci\u00f3n nerviosa y muscular, difieren significativamente en el tipo de nervios afectados, las causas, los signos y s\u00edntomas, la progresi\u00f3n, la prevalencia, el diagn\u00f3stico y el tratamiento.\u00a0<\/p>","protected":false},"author":7,"featured_media":26364,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[5],"tags":[8],"class_list":["post-26361","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cidp","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CIDP vs. ALS: What Is the Difference? - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"This article highlights differences between chronic inflammatory demyelinating polyneuropathy (CIDP) vs. amyotrophic lateral sclerosis\u00a0(ALS).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CIDP vs. ALS: What Is the Difference? - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"This article highlights differences between chronic inflammatory demyelinating polyneuropathy (CIDP) vs. amyotrophic lateral sclerosis\u00a0(ALS).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-26T20:55:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-16T23:38:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"CIDP vs. ALS: What Is the Difference?\",\"datePublished\":\"2024-07-26T20:55:52+00:00\",\"dateModified\":\"2025-07-16T23:38:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/\"},\"wordCount\":815,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/als.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"CIDP\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/\",\"name\":\"CIDP vs. ALS: What Is the Difference? - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/als.jpg\",\"datePublished\":\"2024-07-26T20:55:52+00:00\",\"dateModified\":\"2025-07-16T23:38:38+00:00\",\"description\":\"This article highlights differences between chronic inflammatory demyelinating polyneuropathy (CIDP) vs. amyotrophic lateral sclerosis\u00a0(ALS).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/als.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/als.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Man with ALS in a wheelchair talking to friend\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cidp\\\/cidp-vs-als-what-is-the-difference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CIDP vs. ALS: What Is the Difference?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CIDP vs. ELA: \u00bfCu\u00e1l es la diferencia? - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Este art\u00edculo destaca las diferencias entre la polineuropat\u00eda desmielinizante inflamatoria cr\u00f3nica (PDIC) y la esclerosis lateral amiotr\u00f3fica (ELA).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/","og_locale":"es_MX","og_type":"article","og_title":"CIDP vs. ALS: What Is the Difference? - AmeriPharma\u00ae Specialty Care","og_description":"This article highlights differences between chronic inflammatory demyelinating polyneuropathy (CIDP) vs. amyotrophic lateral sclerosis\u00a0(ALS).","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cidp\/cidp-vs-als-what-is-the-difference\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-07-26T20:55:52+00:00","article_modified_time":"2025-07-16T23:38:38+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"CIDP vs. ALS: What Is the Difference?","datePublished":"2024-07-26T20:55:52+00:00","dateModified":"2025-07-16T23:38:38+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/"},"wordCount":815,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["CIDP"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/","name":"CIDP vs. ELA: \u00bfCu\u00e1l es la diferencia? - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg","datePublished":"2024-07-26T20:55:52+00:00","dateModified":"2025-07-16T23:38:38+00:00","description":"Este art\u00edculo destaca las diferencias entre la polineuropat\u00eda desmielinizante inflamatoria cr\u00f3nica (PDIC) y la esclerosis lateral amiotr\u00f3fica (ELA).","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg","width":1280,"height":853,"caption":"Man with ALS in a wheelchair talking to friend"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cidp\/cidp-vs-als-what-is-the-difference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"CIDP vs. ALS: What Is the Difference?"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Chronic inflammatory demyelinating polyneuropathy (CIDP) and amyotrophic lateral sclerosis\u00a0(ALS) are rare and debilitating neurological disorders. Though both conditions affect nerve and muscle functions, they significantly differ in the type of nerves affected, causes, signs and symptoms, progression, prevalence, diagnosis, and treatment.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/als.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cidp\/\" rel=\"category tag\">CIDP<\/a>","rttpg_excerpt":"Chronic inflammatory demyelinating polyneuropathy (CIDP) and amyotrophic lateral sclerosis\u00a0(ALS) are rare and debilitating neurological disorders. Though both conditions affect nerve and muscle functions, they significantly differ in the type of nerves affected, causes, signs and symptoms, progression, prevalence, diagnosis, and treatment.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/26361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=26361"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/26361\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/26364"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=26361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=26361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=26361"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}